We provide you with 20 years of free, institutional-grade data for BNGO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BNGO. Explore the full financial landscape of BNGO stock.
| Reported Date | CIK | Ticker | Type |
|---|
Bionano Genomics, Inc(NASDAQ:BNGO) 
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the sear...
Website: http://www.bionanogenomics.com
Founded: 2003
Full Time Employees: 97
CEO: Erik Holmlin
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about BNGO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.